Symbols / MITO
MITO Chart
About
No company description available for this symbol.
Fundamentals
Scroll to Statements| Sector | — | Industry | — | Market Cap | — |
| Enterprise Value | — | Income | — | Sales | — |
| Book/sh | — | Cash/sh | — | Dividend Yield | — |
| Payout | — | Employees | — | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | — | P/B | — | P/C | — |
| EV/EBITDA | — | EV/Sales | — | Quick Ratio | — |
| Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | — | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | — | ROA | — |
| ROE | — | ROIC | — | Gross Margin | — |
| Oper. Margin | — | Profit Margin | — | Shs Outstand | — |
| Shs Float | — | Short Float | — | Short Ratio | — |
| Short Interest | — | 52W High | — | 52W Low | — |
| Beta | — | Avg Volume | — | Volume | — |
| Target Price | — | Recom | — | Prev Close | — |
| Price | — | Change | — |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
No analyst ratings or price targets available.
- MITO AI raised $4.5 million to launch project-management software for filmmakers. Read its pitch deck. - Business Insider hu, 29 Jan 2026 08
- Lab-made molecules cut inflammation, a step toward metabolic syndrome drugs - Stock Titan hu, 12 Feb 2026 08
- Mito Securities Posts Strong Nine-Month Profit Growth and Confirms Unchanged Results After Review - TipRanks hu, 12 Feb 2026 08
- Stealth BioTherapeutics Corp Announces Completion of Merger - PR Newswire Wed, 16 Nov 2022 08
- N2OFF tests new molecules to dial down inflammation in human cells - Stock Titan hu, 22 Jan 2026 08
- Mito Securities Delivers Strong Nine-Month Profit Growth and Commits to Minimum Dividend Through 2030 - TipRanks Wed, 28 Jan 2026 08
- Stealth BioTherapeutics'(NASDAQ:MITO) Share Price Is Down 19% Over The Past Year. - Yahoo Finance ue, 06 Jul 2021 07
- INTERPOL Secretary General welcomes G7 commitments on transnational organized crime - Interpol Sun, 10 Dec 2023 08
- GAP43-dependent mitochondria transfer from astrocytes enhances glioblastoma tumorigenicity - Nature hu, 11 May 2023 07
- Here's Why Stealth BioTherapeutics Rocketed Higher Today - The Motley Fool hu, 10 Oct 2019 07
- MITO Corp., Element Electronics Offer TVs for RV Market - RV PRO Fri, 14 Feb 2025 08
- Mitolyn Runs Critically Low In March As Shoppers Flood Verified Retail Channels - The AI Journal Mon, 24 Mar 2025 07
- Minovia brings back SPAC with plans to skate into icy public market - Fierce Biotech Wed, 25 Jun 2025 07
- Quick Look: Drop + MiTo MT3 Noctua Keycap Set - TechPowerUp Wed, 14 Dec 2022 08
- The Short-Termism Myth - The New Yorker Mon, 17 Aug 2015 07
Insider Transactions
No recent insider transactions.
Financials
No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for MITO
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|